The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.

Ziad Ali, MD, explains how coronary computed tomography angiography is creating a major shift in cardiac care.

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

After years of implanting and studying LAAO devices, an interventional cardiologist with the University of Chicago has designed a new alternative that could reduce the risk of bleeding and save health systems money.

The issue, first announced to the public in February, has been linked to 22 serious injuries. Customers are urged to review the updated instructions for use to avoid any potential complications. 

The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.

Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

NT-proBNP measurements are often used to diagnose and manage heart failure. According to a new study of more than 2,000 patients, they can also provide value to cardiologists performing T-TEER.

Recor Medical's Paradise Ultrasound RDN technology is now available in Japan, home to an estimated 43 million adults with hypertension.